Anlon Healthcare Ltd.
•₹ 14.28-0.63%
2026-08-21
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 42.5%
- Company has a healthy return on capital (ROCE) of 20.9%
- Latest quarter profit grew 1251.3% YoY, showing strong momentum
- Operating margins have improved to 26.1% from 11.1%
- Company comfortably covers its interest (10.3x coverage)
- Attractively priced for its growth - PEG of 0.0
CONS
- Operating cash flow has been negative in recent years
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -1.24x)
- Free cash flow has been persistently negative
- Though reporting repeated profits, the company pays out little dividend (0.0%)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | AHCL | 14.52 | 27.07 | 771.76 | 0.00 | 82.81 | — | 875.63 | 1689.56 | 21.98 | 17.81 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 38 | 24 | 9 | 49 | 33 | 52 | 36 | 55 | 310 | |
| 31 | 17 | 9 | 32 | 27 | 38 | 23 | 42 | 251 | |
| Operating Profit | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 10 |
| Depreciation | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 7 |
| 6 | 6 | -0 | 15 | 5 | 12 | 11 | 13 | 59 | |
| Tax % | 31.83% | 57.86% | -758.62% | -7.49% | 29.20% | 25.14% | 51.41% | 22.36% | 18.75% |
| Net Profit | 4 | 3 | -2 | 17 | 4 | 9 | 5 | 10 | 48 |
| 0 | 0 | -1 | 5 | 2 | 2 | 1 | 2 | 0 | |
| Equity Capital | 16 | 40 | 40 | 40 | 40 | 53 | 53 | 53 | 1,063 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 16 | 40 | 40 | 40 | 40 | 53 | 53 | 53 | 1,063 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2024
- 38
- 31
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 6
- Tax %
- 31.83%
- Net Profit
- 4
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 24
- 17
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 6
- Tax %
- 57.86%
- Net Profit
- 3
- 0
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 9
- 9
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- -0
- Tax %
- -758.62%
- Net Profit
- -2
- -1
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 49
- 32
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- 15
- Tax %
- -7.49%
- Net Profit
- 17
- 5
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 33
- 27
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 5
- Tax %
- 29.20%
- Net Profit
- 4
- 2
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 52
- 38
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 12
- Tax %
- 25.14%
- Net Profit
- 9
- 2
- Equity Capital
- 53
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 53
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 36
- 23
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 0
- 11
- Tax %
- 51.41%
- Net Profit
- 5
- 1
- Equity Capital
- 53
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 53
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 55
- 42
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 13
- Tax %
- 22.36%
- Net Profit
- 10
- 2
- Equity Capital
- 53
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 53
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 310
- 251
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 10
- Depreciation
- 7
- 59
- Tax %
- 18.75%
- Net Profit
- 48
- 0
- Equity Capital
- 1,063
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 1,063
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| 57 | 113 | 67 | 120 | 176 | 453 | |
| 52 | 100 | 51 | 88 | 130 | 355 | |
| Operating Profit | 6 | 13 | 16 | 33 | 46 | — |
| OPM % | 10 | 11 | 24 | 27 | 26 | — |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 |
| Interest | 4 | 4 | 4 | 4 | 4 | 13 |
| Depreciation | 2 | 2 | 2 | 2 | 1 | 8 |
| -0 | 7 | 10 | 27 | 41 | 95 | |
| Tax % | 0 | 17 | 1 | 24 | 32 | 24 |
| Net Profit | -0 | 6 | 10 | 21 | 28 | 72 |
| EPS | -0 | 5 | 6 | 5 | 5 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -0 | 0 | 1 | 1 | 1 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -0 | 0 | 1 | 1 | 1 | — |
Mar 2022
- 57
- 52
- Operating Profit
- 6
- OPM %
- 10
- Other Income
- 0
- Interest
- 4
- Depreciation
- 2
- -0
- Tax %
- 0
- Net Profit
- -0
- EPS
- -0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
Mar 2023
- 113
- 100
- Operating Profit
- 13
- OPM %
- 11
- Other Income
- 0
- Interest
- 4
- Depreciation
- 2
- 7
- Tax %
- 17
- Net Profit
- 6
- EPS
- 5
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2024
- 67
- 51
- Operating Profit
- 16
- OPM %
- 24
- Other Income
- 0
- Interest
- 4
- Depreciation
- 2
- 10
- Tax %
- 1
- Net Profit
- 10
- EPS
- 6
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2025
- 120
- 88
- Operating Profit
- 33
- OPM %
- 27
- Other Income
- 0
- Interest
- 4
- Depreciation
- 2
- 27
- Tax %
- 24
- Net Profit
- 21
- EPS
- 5
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2026
- 176
- 130
- Operating Profit
- 46
- OPM %
- 26
- Other Income
- 0
- Interest
- 4
- Depreciation
- 1
- 41
- Tax %
- 32
- Net Profit
- 28
- EPS
- 5
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
TTM
- 453
- 355
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 13
- Depreciation
- 8
- 95
- Tax %
- 24
- Net Profit
- 72
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 16%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 68%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 50%
- 3 Years:
- 43%
- Last Year:
- 19%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - |
| Equity Capital | 12 | 12 | 16 | 40 | 53 |
| -10 | -5 | 5 | 41 | 157 | |
| 8 | 8 | 20 | 20 | 43 | |
| Trade Payables | 15 | 25 | 20 | 20 | 39 |
| 60 | 71 | 67 | 61 | 25 | |
| Total Liabilities | 85 | 112 | 128 | 181 | 317 |
| ASSETS | - | - | - | - | - |
| 27 | 26 | 27 | 23 | 40 | |
| 2 | 4 | 1 | 1 | 10 | |
| 27 | 27 | 42 | 50 | 76 | |
| 0 | 0 | 39 | 75 | 104 | |
| Cash & Bank | 2 | 1 | 2 | 1 | 3 |
| 28 | 54 | 17 | 31 | 83 | |
| Total Assets | 85 | 112 | 128 | 181 | 317 |
| Total Debt | 62 | 70 | 81 | 67 | 46 |
| Net Working Capital | 29 | 42 | 51 | 98 | 159 |
| Contingent Liabilities | 2 | 2 | 3 | 0 | 0 |
| Book Value per Share | 1.30 | 6.15 | 13.14 | 20.18 | 39.47 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 62 | 70 | 81 | 67 | 46 |
| Net Working Capital | 29 | 42 | 51 | 98 | 159 |
| Contingent Liabilities | 2 | 2 | 3 | 0 | 0 |
| Book Value per Share | 1.30 | 6.15 | 13.14 | 20.18 | 39.47 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2022
- Equity Capital
- 12
- -10
- 8
- Trade Payables
- 15
- 60
- Total Liabilities
- 85
- 27
- 2
- 27
- 0
- Cash & Bank
- 2
- 28
- Total Assets
- 85
- Total Debt
- 62
- Net Working Capital
- 29
- Contingent Liabilities
- 2
- Book Value per Share
- 1.30
- Face Value
- 10.00
- Total Debt
- 62
- Net Working Capital
- 29
- Contingent Liabilities
- 2
- Book Value per Share
- 1.30
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 12
- -5
- 8
- Trade Payables
- 25
- 71
- Total Liabilities
- 112
- 26
- 4
- 27
- 0
- Cash & Bank
- 1
- 54
- Total Assets
- 112
- Total Debt
- 70
- Net Working Capital
- 42
- Contingent Liabilities
- 2
- Book Value per Share
- 6.15
- Face Value
- 10.00
- Total Debt
- 70
- Net Working Capital
- 42
- Contingent Liabilities
- 2
- Book Value per Share
- 6.15
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 16
- 5
- 20
- Trade Payables
- 20
- 67
- Total Liabilities
- 128
- 27
- 1
- 42
- 39
- Cash & Bank
- 2
- 17
- Total Assets
- 128
- Total Debt
- 81
- Net Working Capital
- 51
- Contingent Liabilities
- 3
- Book Value per Share
- 13.14
- Face Value
- 10.00
- Total Debt
- 81
- Net Working Capital
- 51
- Contingent Liabilities
- 3
- Book Value per Share
- 13.14
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 40
- 41
- 20
- Trade Payables
- 20
- 61
- Total Liabilities
- 181
- 23
- 1
- 50
- 75
- Cash & Bank
- 1
- 31
- Total Assets
- 181
- Total Debt
- 67
- Net Working Capital
- 98
- Contingent Liabilities
- 0
- Book Value per Share
- 20.18
- Face Value
- 10.00
- Total Debt
- 67
- Net Working Capital
- 98
- Contingent Liabilities
- 0
- Book Value per Share
- 20.18
- Face Value
- 10.00
Mar 2026
- Equity Capital
- 53
- 157
- 43
- Trade Payables
- 39
- 25
- Total Liabilities
- 317
- 40
- 10
- 76
- 104
- Cash & Bank
- 3
- 83
- Total Assets
- 317
- Total Debt
- 46
- Net Working Capital
- 159
- Contingent Liabilities
- 0
- Book Value per Share
- 39.47
- Face Value
- 10.00
- Total Debt
- 46
- Net Working Capital
- 159
- Contingent Liabilities
- 0
- Book Value per Share
- 39.47
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| -2 | -3 | -3 | -23 | -46 | |
| Cash from Investing | -0 | -0 | -3 | 3 | -28 |
| Cash from Financing | 3 | 2 | 8 | 19 | 76 |
| 1 | -1 | 2 | -1 | 2 | |
| Free Cash Flow | -2 | -3 | -7 | -23 | -65 |
| OCF / Net Profit | 16.29 | -0.49 | -0.33 | -1.10 | -1.67 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
| OCF / Net Profit | 16.29 | -0.49 | -0.33 | -1.10 | -1.67 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
Mar 2022
- -2
- Cash from Investing
- -0
- Cash from Financing
- 3
- 1
- Free Cash Flow
- -2
- OCF / Net Profit
- 16.29
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 16.29
- Cumulative 5-Year FCF
- 0
Mar 2023
- -3
- Cash from Investing
- -0
- Cash from Financing
- 2
- -1
- Free Cash Flow
- -3
- OCF / Net Profit
- -0.49
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.49
- Cumulative 5-Year FCF
- 0
Mar 2024
- -3
- Cash from Investing
- -3
- Cash from Financing
- 8
- 2
- Free Cash Flow
- -7
- OCF / Net Profit
- -0.33
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.33
- Cumulative 5-Year FCF
- 0
Mar 2025
- -23
- Cash from Investing
- 3
- Cash from Financing
- 19
- -1
- Free Cash Flow
- -23
- OCF / Net Profit
- -1.10
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.10
- Cumulative 5-Year FCF
- 0
Mar 2026
- -46
- Cash from Investing
- -28
- Cash from Financing
- 76
- 2
- Free Cash Flow
- -65
- OCF / Net Profit
- -1.67
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.67
- Cumulative 5-Year FCF
- 0
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - |
| EPS (₹) | -0.09 | 4.85 | 6.04 | 5.15 | 5.23 |
| Book Value (₹) | 1.30 | 6.15 | 13.14 | 20.18 | 39.47 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 0.14 | 0.64 | 0.72 | 0.56 | 0.55 |
| PROFITABILITY | - | - | - | - | - |
| Operating Margin % | 10.41% | 11.11% | 23.59% | 27.06% | 26.14% |
| Net Margin % | -0.19% | 5.16% | 14.50% | 17.06% | 15.76% |
| ROE % | -6.93% | 130.37% | 67.99% | 40.45% | 19.17% |
| ROCE % | 6.42% | 15.42% | 15.48% | 24.83% | 22.38% |
| -0.13% | 5.92% | 8.06% | 13.27% | 11.16% | |
| EFFICIENCY | - | - | - | - | - |
| Debtor Days | 130 | 104 | 226 | 173 | 185 |
| Inventory Days | 170 | 87 | 188 | 140 | 130 |
| Payable Days | 128 | 84 | 246 | 97 | 96 |
| 172 | 106 | 169 | 215 | 220 | |
| FINANCIAL HEALTH | - | - | - | - | - |
| Debt to Equity (x) | 40.14x | 9.54x | 3.86x | 0.83x | 0.22x |
| Interest Coverage (x) | 0.97x | 2.78x | 3.33x | 7.63x | 10.34x |
| 2.00x | 1.97x | 2.01x | 2.64x | 2.57x | |
| GROWTH | - | - | - | - | - |
| Revenue Growth % | 0.00% | 97.54% | -41.01% | 80.65% | 46.73% |
| Operating Profit Growth % | 0.00% | 114.98% | 23.69% | 106.87% | 41.79% |
| Net Profit Growth % | 0.00% | 5503.90% | 65.93% | 112.47% | 35.53% |
| 0.00% | 5503.90% | 24.45% | -14.70% | 1.62% | |
| VALUATION | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 2.13x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 2.82x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 6.39x | 6.00x | 3.21x | 13.66x |
Mar 2022
- EPS (₹)
- -0.09
- Book Value (₹)
- 1.30
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.14
- Operating Margin %
- 10.41%
- Net Margin %
- -0.19%
- ROE %
- -6.93%
- ROCE %
- 6.42%
- -0.13%
- Debtor Days
- 130
- Inventory Days
- 170
- Payable Days
- 128
- 172
- Debt to Equity (x)
- 40.14x
- Interest Coverage (x)
- 0.97x
- 2.00x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 4.85
- Book Value (₹)
- 6.15
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.64
- Operating Margin %
- 11.11%
- Net Margin %
- 5.16%
- ROE %
- 130.37%
- ROCE %
- 15.42%
- 5.92%
- Debtor Days
- 104
- Inventory Days
- 87
- Payable Days
- 84
- 106
- Debt to Equity (x)
- 9.54x
- Interest Coverage (x)
- 2.78x
- 1.97x
- Revenue Growth %
- 97.54%
- Operating Profit Growth %
- 114.98%
- Net Profit Growth %
- 5503.90%
- 5503.90%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 6.39x
Mar 2024
- EPS (₹)
- 6.04
- Book Value (₹)
- 13.14
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.72
- Operating Margin %
- 23.59%
- Net Margin %
- 14.50%
- ROE %
- 67.99%
- ROCE %
- 15.48%
- 8.06%
- Debtor Days
- 226
- Inventory Days
- 188
- Payable Days
- 246
- 169
- Debt to Equity (x)
- 3.86x
- Interest Coverage (x)
- 3.33x
- 2.01x
- Revenue Growth %
- -41.01%
- Operating Profit Growth %
- 23.69%
- Net Profit Growth %
- 65.93%
- 24.45%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 6.00x
Mar 2025
- EPS (₹)
- 5.15
- Book Value (₹)
- 20.18
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.56
- Operating Margin %
- 27.06%
- Net Margin %
- 17.06%
- ROE %
- 40.45%
- ROCE %
- 24.83%
- 13.27%
- Debtor Days
- 173
- Inventory Days
- 140
- Payable Days
- 97
- 215
- Debt to Equity (x)
- 0.83x
- Interest Coverage (x)
- 7.63x
- 2.64x
- Revenue Growth %
- 80.65%
- Operating Profit Growth %
- 106.87%
- Net Profit Growth %
- 112.47%
- -14.70%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 3.21x
Mar 2026
- EPS (₹)
- 5.23
- Book Value (₹)
- 39.47
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.55
- Operating Margin %
- 26.14%
- Net Margin %
- 15.76%
- ROE %
- 19.17%
- ROCE %
- 22.38%
- 11.16%
- Debtor Days
- 185
- Inventory Days
- 130
- Payable Days
- 96
- 220
- Debt to Equity (x)
- 0.22x
- Interest Coverage (x)
- 10.34x
- 2.57x
- Revenue Growth %
- 46.73%
- Operating Profit Growth %
- 41.79%
- Net Profit Growth %
- 35.53%
- 1.62%
- P/E (x)
- 2.13x
- P/B (x)
- 2.82x
- Dividend Yield %
- 0.00%
- 13.66x
Documents
Announcements
- Copy of Newspaper Publication
2026-08-17 - Anlon Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
- Shareholders meeting
2026-08-14 - Anlon Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 05, 2026
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
Jun 2026
Feb 2026